NCT05362773
A Study of MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies
Registry record
- Lead sponsor
- MacroGenics
- Conditions
- Leukemia, Acute Myeloid; Myelodysplastic Syndromes; Classical Hodgkin Lymphoma; Leukemia, B-cell; Leukemia, Hairy Cell
- Primary completion
- Nov 2026Sponsor estimate
- Completion
- Locked
- Start
- Locked
- Enrollment
- Locked
- Interventions
- Locked
- Study type
- Locked
- Results on the registry
- Locked
- Record last updated
- Locked
Sponsor estimate: the sponsor registered this date in advance and can move it. A primary completion date is when the last participant is measured, not when results are announced.
Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScannerRecorded changes
0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.
Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.